A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19-Reference-Cited by-同舟云学术

A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19

Published:2022-04 Issue:4 Volume:3 Page:233-248.e6
ISSN:2666-6340
Container-title:Med
language:en
Short-container-title:Med

Author:

McElvaney Oliver J.^ORCID,McEvoy Natalie L.,Boland Fiona,McElvaney Oisín F.,Hogan Grace,Donnelly Karen,Friel Oisín,Browne Emmet,Fraughen Daniel D.,Murphy Mark P.,Clarke Jennifer,Choileáin Orna Ní,O’Connor Eoin,McGuinness Rory,Boylan Maria,Kelly Alan,Hayden John C.,Collins Ann M.,Cullen Ailbhe,Hyland Deirdre,Carroll Tomás P.,Geoghegan Pierce,Laffey John G.,Hennessy Martina,Martin-Loeches Ignacio,McElvaney Noel G.,Curley Gerard F.

Publisher

Elsevier BV

Subject

General Medicine

Reference80 articles.

1. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China;Wu;JAMA Intern. Med.,2020

2. Severe covid-19;Berlin;N. Engl. J. Med.,2020

3. Characterization of the inflammatory response to severe COVID-19 illness;McElvaney;Am. J. Respir. Crit. Care Med.,2020

4. Acute respiratory distress syndrome;Thompson;N. Engl. J. Med.,2017

5. Acute respiratory distress syndrome;Matthay;Nat. Rev. Dis. Primers,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of serum albumin in the field of drug delivery;Interdisciplinary Medicine;2024-07

2. A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning;Clinical Proteomics;2024-05-17

3. Investigational pharmacological agents for the treatment of ARDS;Expert Opinion on Investigational Drugs;2024-02-27

4. Neutrophil Activity and Extracellular Matrix Degradation: Drivers of Lung Tissue Destruction in Fatal COVID-19 Cases and Implications for Long COVID;Biomolecules;2024-02-17

5. Undiagnosed Alpha-1 Antitrypsin Deficiency and the Perpetuation of Lung Health Inequity;American Journal of Respiratory and Critical Care Medicine;2024-01-01